Early anticoagulation associated with reduced mortality for acute pulmonary embolism

Latest 5 articles from heartwire

Fidelis failures climb: "Strongly consider" replacement at ICD change-out
Feb 10, 2012 17:00 EDT
New mitral-repair therapies face obstacles
Feb 10, 2012 16:30 EDT
More doctors advising patients to exercise
Feb 10, 2012 14:45 EDT
More hope for factor Xa reversal
Feb 10, 2012 14:00 EDT
The doctor will see you now (from the other side of the world)
Feb 10, 2012 12:30 EDT

Early anticoagulation associated with reduced mortality for acute pulmonary embolism

Posted Feb 02, 2010 at 10:55 AM, EDT by Samuel Goldhaber

A recent article in Chest discusses how early anticoagulation in the emergency setting reduced mortality from pulmonary embolism with no increase in major hemorrhage. We can conclude that whenever there is suspicion of pulmonary embolism, the patient should be aggressively and rapidly anticoagulated as long as there are no contraindications.

See:

Smith SB, Geske JB et al. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest 2009: DOI 10.1378/chest.09-0959.

1 Comments | Add your own comments |

Share this post:

Permalink

« Previous

Comments

soy internista y profesor de internado pregrado me interesa trombosis venosa epidemiologia y hipertension arterial e insuficieicnia cardiaca gracias

Posted by jesus chavez barron, Mar 20, 2010 at 08:21 PM, EDT

Reply to this comment

Add your own comments

E-mail: (not shared)

Display name:

Notify me of replies (via email):

Your comment:

This blog on theheart.org is a sounding board for healthcare providers, clinicians, and researchers, and is not intended to supply answers or advice to patients. We reserve the right to remove posts containing inappropriate language, promotional content, personal agendas or hostile intent, and posts from patients asking for medical advice.

In the interest of promoting a balanced exchange, please disclose any relevant relationships or conflicts of interest when posting your comment.

The views and opinions expressed herein are those of the blogger and do not necessarily reflect those of theheart.org.

Preventing postthrombotic syndrome: CAVENT supports the "open vein hypothesis"

No comments | Posted Feb 10, 2012
at 09:20 AM, EDT by Samuel

IVC filters: The genie's out of the bottle

No comments | Posted Feb 03, 2012
at 08:30 AM, EDT by Samuel

Emergency hospitalization from adverse drug events: Warfarin the biggest culprit

No comments | Posted Jan 27, 2012
at 08:50 AM, EDT by Samuel

Self-monitoring INR and self-managing warfarin to reduce thromboembolic events

4 Comments | Posted Jan 20, 2012
at 07:30 AM, EDT by Samuel

LIFENOX: No advantage of VTE prophylaxis in hospitalized medical service patients

1 Comments | Posted Jan 13, 2012
at 09:20 AM, EDT by Samuel

Also from theheart.org

Trials and PIs

Topolog

The Bob Harrington Show

Private practice with Dr Seth Bilazarian

This week in cardiology from heartwire

Cutting-edge dialogues with Drs Tim Gardner and Mat Williams

Heartfelt with Dr Melissa Walton-Shirley

Fellows' corner

Topol and Teirstein: The Click and Rub Show

Heart failure and transplantation with Dr Ileana Piña

Blogs I read

North American Thrombosis Forum

Who's Talking

Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA